AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?

AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?  The Motley Fool

Summary aggregated from The Motley Fool's public RSS feed. The full reporting belongs to The Motley Fool — please read it on their site.